To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

Phase I FOLFOX Combination

NCT00499850 ·Status: COMPLETED ·Phase: PHASE1

Neoadjuvant Therapy for Locally Advanced Colon Cancer

NCT04625803 ·Status: COMPLETED ·Phase: PHASE2

FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer

NCT05627635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

NCT00826800 ·Status: TERMINATED ·Phase: NA

Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

NCT01675999 ·Status: UNKNOWN ·Phase: PHASE2

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

NCT06959693 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer

NCT02384850 ·Status: TERMINATED ·Phase: PHASE1

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146 ·Status: COMPLETED ·Phase: NA

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

NCT05378919 ·Status: RECRUITING ·Phase: PHASE2

Adjuvant Chemotherapy in High Risk Stage II Colon Cancer

NCT04303429 ·Status: UNKNOWN ·Phase: PHASE3

Chemotherapy Combined With CIK Treating Colon Cancer

NCT03084809 ·Status: COMPLETED ·Phase: PHASE4

Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer

NCT06368141 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC

NCT02948985 ·Status: UNKNOWN

A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets

NCT06972498 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery

NCT00321828 ·Status: COMPLETED ·Phase: PHASE2

Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer

NCT00005050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

NCT00752570 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

NCT00056030 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

NCT00513266 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

NCT03487939 ·Status: UNKNOWN ·Phase: PHASE2

Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery

NCT00544349 ·Status: COMPLETED ·Phase: PHASE2

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

NCT00005036 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer

NCT06115174 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

NCT01736904 ·Status: UNKNOWN ·Phase: PHASE2

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00003001 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2